Why Is CANF Stock Surging Today?
Shares of Can-Fite BioPharma (CANF) surged on Wednesday after the company announced positive early-stage study results for its treatment targeting pancreatic tumors.At the time of writing, CANF shares were up more than 50%, reaching their highest level in nearly three months.Can-Fite’s Study Result…